nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclobenzaprine—CYP2D6—Temsirolimus—kidney cancer	0.096	0.136	CbGbCtD
Cyclobenzaprine—CYP3A4—Everolimus—kidney cancer	0.0904	0.128	CbGbCtD
Cyclobenzaprine—CYP1A2—Pazopanib—kidney cancer	0.0612	0.0865	CbGbCtD
Cyclobenzaprine—CYP3A4—Temsirolimus—kidney cancer	0.0611	0.0863	CbGbCtD
Cyclobenzaprine—CYP2D6—Pazopanib—kidney cancer	0.0504	0.0713	CbGbCtD
Cyclobenzaprine—CYP1A2—Erlotinib—kidney cancer	0.0437	0.0617	CbGbCtD
Cyclobenzaprine—CYP2D6—Erlotinib—kidney cancer	0.036	0.0509	CbGbCtD
Cyclobenzaprine—CYP1A2—Sorafenib—kidney cancer	0.0355	0.0502	CbGbCtD
Cyclobenzaprine—CYP3A4—Pazopanib—kidney cancer	0.0321	0.0453	CbGbCtD
Cyclobenzaprine—CYP2D6—Sorafenib—kidney cancer	0.0293	0.0414	CbGbCtD
Cyclobenzaprine—CYP2D6—Vinblastine—kidney cancer	0.0289	0.0408	CbGbCtD
Cyclobenzaprine—CYP3A4—Erlotinib—kidney cancer	0.0229	0.0323	CbGbCtD
Cyclobenzaprine—CYP3A4—Paclitaxel—kidney cancer	0.021	0.0296	CbGbCtD
Cyclobenzaprine—CYP3A4—Sorafenib—kidney cancer	0.0186	0.0263	CbGbCtD
Cyclobenzaprine—CYP3A4—Vinblastine—kidney cancer	0.0184	0.026	CbGbCtD
Cyclobenzaprine—CYP3A4—Vincristine—kidney cancer	0.0181	0.0255	CbGbCtD
Cyclobenzaprine—CYP2D6—Doxorubicin—kidney cancer	0.0178	0.0251	CbGbCtD
Cyclobenzaprine—CYP3A4—Sunitinib—kidney cancer	0.0151	0.0213	CbGbCtD
Cyclobenzaprine—CYP3A4—Doxorubicin—kidney cancer	0.0113	0.016	CbGbCtD
Cyclobenzaprine—Olopatadine—S100A1—kidney cancer	0.00511	0.631	CrCbGaD
Cyclobenzaprine—CYP1A2—urine—kidney cancer	0.00186	0.213	CbGeAlD
Cyclobenzaprine—HTR2A—urine—kidney cancer	0.00145	0.166	CbGeAlD
Cyclobenzaprine—Dimetacrine—ACHE—kidney cancer	0.00136	0.168	CrCbGaD
Cyclobenzaprine—CYP3A4—urine—kidney cancer	0.00135	0.154	CbGeAlD
Cyclobenzaprine—CYP2D6—urine—kidney cancer	0.00132	0.151	CbGeAlD
Cyclobenzaprine—CYP1A2—renal system—kidney cancer	0.000455	0.052	CbGeAlD
Cyclobenzaprine—HTR2A—renal system—kidney cancer	0.000356	0.0407	CbGeAlD
Cyclobenzaprine—HTR2A—kidney—kidney cancer	0.000344	0.0393	CbGeAlD
Cyclobenzaprine—CYP3A4—renal system—kidney cancer	0.000329	0.0377	CbGeAlD
Cyclobenzaprine—CYP2D6—renal system—kidney cancer	0.000324	0.0371	CbGeAlD
Cyclobenzaprine—HTR2A—gonad—kidney cancer	0.000319	0.0365	CbGeAlD
Cyclobenzaprine—CYP3A4—kidney—kidney cancer	0.000318	0.0364	CbGeAlD
Cyclobenzaprine—CYP2D6—kidney—kidney cancer	0.000313	0.0358	CbGeAlD
Cyclobenzaprine—Protriptyline—ABCB1—kidney cancer	0.000273	0.0337	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Sorafenib—kidney cancer	0.000271	0.000991	CcSEcCtD
Cyclobenzaprine—Insomnia—Vincristine—kidney cancer	0.000271	0.00099	CcSEcCtD
Cyclobenzaprine—Anorexia—Gemcitabine—kidney cancer	0.000271	0.00099	CcSEcCtD
Cyclobenzaprine—Vomiting—Vinblastine—kidney cancer	0.00027	0.000989	CcSEcCtD
Cyclobenzaprine—Dizziness—Erlotinib—kidney cancer	0.00027	0.000988	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Paclitaxel—kidney cancer	0.00027	0.000988	CcSEcCtD
Cyclobenzaprine—Vomiting—Everolimus—kidney cancer	0.000269	0.000985	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Vincristine—kidney cancer	0.000269	0.000983	CcSEcCtD
Cyclobenzaprine—Agitation—Paclitaxel—kidney cancer	0.000268	0.000979	CcSEcCtD
Cyclobenzaprine—Rash—Everolimus—kidney cancer	0.000267	0.000977	CcSEcCtD
Cyclobenzaprine—Dermatitis—Everolimus—kidney cancer	0.000267	0.000976	CcSEcCtD
Cyclobenzaprine—Headache—Vinblastine—kidney cancer	0.000266	0.000974	CcSEcCtD
Cyclobenzaprine—Angioedema—Paclitaxel—kidney cancer	0.000266	0.000973	CcSEcCtD
Cyclobenzaprine—Purpura—Doxorubicin—kidney cancer	0.000265	0.000971	CcSEcCtD
Cyclobenzaprine—Headache—Everolimus—kidney cancer	0.000265	0.00097	CcSEcCtD
Cyclobenzaprine—Hypotension—Gemcitabine—kidney cancer	0.000265	0.00097	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Dactinomycin—kidney cancer	0.000265	0.000968	CcSEcCtD
Cyclobenzaprine—Asthenia—Sorafenib—kidney cancer	0.000264	0.000965	CcSEcCtD
Cyclobenzaprine—Malaise—Paclitaxel—kidney cancer	0.000263	0.00096	CcSEcCtD
Cyclobenzaprine—Vertigo—Paclitaxel—kidney cancer	0.000262	0.000957	CcSEcCtD
Cyclobenzaprine—Syncope—Paclitaxel—kidney cancer	0.000261	0.000955	CcSEcCtD
Cyclobenzaprine—Cerebrovascular accident—Doxorubicin—kidney cancer	0.000261	0.000955	CcSEcCtD
Cyclobenzaprine—Leukopenia—Paclitaxel—kidney cancer	0.000261	0.000953	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Sunitinib—kidney cancer	0.000261	0.000953	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Vincristine—kidney cancer	0.00026	0.000951	CcSEcCtD
Cyclobenzaprine—Pruritus—Sorafenib—kidney cancer	0.00026	0.000951	CcSEcCtD
Cyclobenzaprine—Vomiting—Erlotinib—kidney cancer	0.00026	0.00095	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	0.000259	0.000946	CcSEcCtD
Cyclobenzaprine—Fatigue—Vincristine—kidney cancer	0.000258	0.000944	CcSEcCtD
Cyclobenzaprine—Rash—Erlotinib—kidney cancer	0.000258	0.000942	CcSEcCtD
Cyclobenzaprine—Dermatitis—Erlotinib—kidney cancer	0.000258	0.000942	CcSEcCtD
Cyclobenzaprine—Palpitations—Paclitaxel—kidney cancer	0.000257	0.000941	CcSEcCtD
Cyclobenzaprine—Insomnia—Gemcitabine—kidney cancer	0.000257	0.000939	CcSEcCtD
Cyclobenzaprine—Headache—Erlotinib—kidney cancer	0.000256	0.000936	CcSEcCtD
Cyclobenzaprine—Tinnitus—Capecitabine—kidney cancer	0.000256	0.000936	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Paclitaxel—kidney cancer	0.000256	0.000936	CcSEcCtD
Cyclobenzaprine—Constipation—Vincristine—kidney cancer	0.000256	0.000936	CcSEcCtD
Cyclobenzaprine—Diplopia—Doxorubicin—kidney cancer	0.000256	0.000936	CcSEcCtD
Cyclobenzaprine—Osteoarthritis—Doxorubicin—kidney cancer	0.000256	0.000936	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Gemcitabine—kidney cancer	0.000255	0.000932	CcSEcCtD
Cyclobenzaprine—Asthenia—Sunitinib—kidney cancer	0.000254	0.000928	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Gemcitabine—kidney cancer	0.000253	0.000926	CcSEcCtD
Cyclobenzaprine—Nausea—Vinblastine—kidney cancer	0.000253	0.000924	CcSEcCtD
Cyclobenzaprine—Somnolence—Gemcitabine—kidney cancer	0.000252	0.000923	CcSEcCtD
Cyclobenzaprine—Convulsion—Paclitaxel—kidney cancer	0.000252	0.000923	CcSEcCtD
Cyclobenzaprine—Nausea—Everolimus—kidney cancer	0.000252	0.00092	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Sorafenib—kidney cancer	0.000252	0.00092	CcSEcCtD
Cyclobenzaprine—Hypertension—Paclitaxel—kidney cancer	0.000251	0.00092	CcSEcCtD
Cyclobenzaprine—Pruritus—Sunitinib—kidney cancer	0.00025	0.000915	CcSEcCtD
Cyclobenzaprine—Chest pain—Paclitaxel—kidney cancer	0.000248	0.000907	CcSEcCtD
Cyclobenzaprine—Myalgia—Paclitaxel—kidney cancer	0.000248	0.000907	CcSEcCtD
Cyclobenzaprine—Anxiety—Paclitaxel—kidney cancer	0.000247	0.000904	CcSEcCtD
Cyclobenzaprine—Face oedema—Doxorubicin—kidney cancer	0.000247	0.000903	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Gemcitabine—kidney cancer	0.000247	0.000903	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Dactinomycin—kidney cancer	0.000247	0.000902	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Capecitabine—kidney cancer	0.000245	0.000897	CcSEcCtD
Cyclobenzaprine—Discomfort—Paclitaxel—kidney cancer	0.000245	0.000896	CcSEcCtD
Cyclobenzaprine—Fatigue—Gemcitabine—kidney cancer	0.000245	0.000895	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Vincristine—kidney cancer	0.000245	0.000895	CcSEcCtD
Cyclobenzaprine—Dizziness—Sorafenib—kidney cancer	0.000243	0.000889	CcSEcCtD
Cyclobenzaprine—Constipation—Gemcitabine—kidney cancer	0.000243	0.000888	CcSEcCtD
Cyclobenzaprine—Nausea—Erlotinib—kidney cancer	0.000243	0.000888	CcSEcCtD
Cyclobenzaprine—Alopecia—Capecitabine—kidney cancer	0.000243	0.000887	CcSEcCtD
Cyclobenzaprine—Dry mouth—Paclitaxel—kidney cancer	0.000243	0.000887	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Sunitinib—kidney cancer	0.000242	0.000885	CcSEcCtD
Cyclobenzaprine—Ataxia—Doxorubicin—kidney cancer	0.000241	0.00088	CcSEcCtD
Cyclobenzaprine—Asthenia—Dactinomycin—kidney cancer	0.00024	0.000879	CcSEcCtD
Cyclobenzaprine—Confusional state—Paclitaxel—kidney cancer	0.00024	0.000876	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Paclitaxel—kidney cancer	0.000238	0.000869	CcSEcCtD
Cyclobenzaprine—Oedema—Paclitaxel—kidney cancer	0.000238	0.000869	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Vincristine—kidney cancer	0.000237	0.000865	CcSEcCtD
Cyclobenzaprine—Flatulence—Capecitabine—kidney cancer	0.000236	0.000861	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Capecitabine—kidney cancer	0.000234	0.000856	CcSEcCtD
Cyclobenzaprine—Dizziness—Sunitinib—kidney cancer	0.000234	0.000856	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Gemcitabine—kidney cancer	0.000234	0.000856	CcSEcCtD
Cyclobenzaprine—Shock—Paclitaxel—kidney cancer	0.000234	0.000855	CcSEcCtD
Cyclobenzaprine—Vomiting—Sorafenib—kidney cancer	0.000234	0.000855	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Paclitaxel—kidney cancer	0.000233	0.000851	CcSEcCtD
Cyclobenzaprine—Tachycardia—Paclitaxel—kidney cancer	0.000232	0.000848	CcSEcCtD
Cyclobenzaprine—Rash—Sorafenib—kidney cancer	0.000232	0.000848	CcSEcCtD
Cyclobenzaprine—Dermatitis—Sorafenib—kidney cancer	0.000232	0.000847	CcSEcCtD
Cyclobenzaprine—Headache—Sorafenib—kidney cancer	0.00023	0.000842	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Paclitaxel—kidney cancer	0.00023	0.00084	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Dactinomycin—kidney cancer	0.000229	0.000838	CcSEcCtD
Cyclobenzaprine—Anorexia—Paclitaxel—kidney cancer	0.000227	0.000829	CcSEcCtD
Cyclobenzaprine—Gastritis—Doxorubicin—kidney cancer	0.000226	0.000828	CcSEcCtD
Cyclobenzaprine—Vision blurred—Capecitabine—kidney cancer	0.000225	0.000824	CcSEcCtD
Cyclobenzaprine—Vomiting—Sunitinib—kidney cancer	0.000225	0.000823	CcSEcCtD
Cyclobenzaprine—Tremor—Capecitabine—kidney cancer	0.000224	0.000819	CcSEcCtD
Cyclobenzaprine—Rash—Sunitinib—kidney cancer	0.000223	0.000816	CcSEcCtD
Cyclobenzaprine—Dermatitis—Sunitinib—kidney cancer	0.000223	0.000815	CcSEcCtD
Cyclobenzaprine—Hypotension—Paclitaxel—kidney cancer	0.000222	0.000812	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Capecitabine—kidney cancer	0.000222	0.000811	CcSEcCtD
Cyclobenzaprine—Headache—Sunitinib—kidney cancer	0.000222	0.000811	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Vincristine—kidney cancer	0.000221	0.000806	CcSEcCtD
Cyclobenzaprine—Eosinophilia—Doxorubicin—kidney cancer	0.000219	0.000801	CcSEcCtD
Cyclobenzaprine—Nausea—Sorafenib—kidney cancer	0.000218	0.000799	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	0.000217	0.000792	CcSEcCtD
Cyclobenzaprine—Malaise—Capecitabine—kidney cancer	0.000216	0.000788	CcSEcCtD
Cyclobenzaprine—Nortriptyline—PTGS1—kidney cancer	0.000215	0.0266	CrCbGaD
Cyclobenzaprine—Insomnia—Paclitaxel—kidney cancer	0.000215	0.000786	CcSEcCtD
Cyclobenzaprine—Vertigo—Capecitabine—kidney cancer	0.000215	0.000785	CcSEcCtD
Cyclobenzaprine—Asthenia—Vincristine—kidney cancer	0.000215	0.000785	CcSEcCtD
Cyclobenzaprine—Syncope—Capecitabine—kidney cancer	0.000214	0.000784	CcSEcCtD
Cyclobenzaprine—Leukopenia—Capecitabine—kidney cancer	0.000214	0.000782	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Paclitaxel—kidney cancer	0.000213	0.000781	CcSEcCtD
Cyclobenzaprine—Vomiting—Dactinomycin—kidney cancer	0.000213	0.000779	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Paclitaxel—kidney cancer	0.000212	0.000775	CcSEcCtD
Cyclobenzaprine—Somnolence—Paclitaxel—kidney cancer	0.000211	0.000773	CcSEcCtD
Cyclobenzaprine—Palpitations—Capecitabine—kidney cancer	0.000211	0.000772	CcSEcCtD
Cyclobenzaprine—Rash—Dactinomycin—kidney cancer	0.000211	0.000772	CcSEcCtD
Cyclobenzaprine—Nausea—Sunitinib—kidney cancer	0.00021	0.000769	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Capecitabine—kidney cancer	0.00021	0.000768	CcSEcCtD
Cyclobenzaprine—Pancytopenia—Doxorubicin—kidney cancer	0.00021	0.000768	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Paclitaxel—kidney cancer	0.000209	0.000765	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Paclitaxel—kidney cancer	0.000207	0.000756	CcSEcCtD
Cyclobenzaprine—Hypertension—Capecitabine—kidney cancer	0.000206	0.000755	CcSEcCtD
Cyclobenzaprine—Upper respiratory tract infection—Doxorubicin—kidney cancer	0.000206	0.000752	CcSEcCtD
Cyclobenzaprine—Fatigue—Paclitaxel—kidney cancer	0.000205	0.000749	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Vincristine—kidney cancer	0.000205	0.000749	CcSEcCtD
Cyclobenzaprine—Pollakiuria—Doxorubicin—kidney cancer	0.000204	0.000747	CcSEcCtD
Cyclobenzaprine—Asthenia—Gemcitabine—kidney cancer	0.000204	0.000745	CcSEcCtD
Cyclobenzaprine—Chest pain—Capecitabine—kidney cancer	0.000204	0.000744	CcSEcCtD
Cyclobenzaprine—Myalgia—Capecitabine—kidney cancer	0.000204	0.000744	CcSEcCtD
Cyclobenzaprine—Constipation—Paclitaxel—kidney cancer	0.000203	0.000743	CcSEcCtD
Cyclobenzaprine—Anxiety—Capecitabine—kidney cancer	0.000203	0.000742	CcSEcCtD
Cyclobenzaprine—Weight increased—Doxorubicin—kidney cancer	0.000201	0.000736	CcSEcCtD
Cyclobenzaprine—Discomfort—Capecitabine—kidney cancer	0.000201	0.000735	CcSEcCtD
Cyclobenzaprine—Pruritus—Gemcitabine—kidney cancer	0.000201	0.000735	CcSEcCtD
Cyclobenzaprine—Dry mouth—Capecitabine—kidney cancer	0.000199	0.000728	CcSEcCtD
Cyclobenzaprine—Nausea—Dactinomycin—kidney cancer	0.000199	0.000728	CcSEcCtD
Cyclobenzaprine—Diphenhydramine—PTGS1—kidney cancer	0.000199	0.0246	CrCbGaD
Cyclobenzaprine—Dizziness—Vincristine—kidney cancer	0.000198	0.000724	CcSEcCtD
Cyclobenzaprine—Drowsiness—Doxorubicin—kidney cancer	0.000197	0.000721	CcSEcCtD
Cyclobenzaprine—Confusional state—Capecitabine—kidney cancer	0.000197	0.000719	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Paclitaxel—kidney cancer	0.000196	0.000716	CcSEcCtD
Cyclobenzaprine—Oedema—Capecitabine—kidney cancer	0.000195	0.000713	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Paclitaxel—kidney cancer	0.000194	0.000711	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Gemcitabine—kidney cancer	0.000194	0.00071	CcSEcCtD
Cyclobenzaprine—Neuropathy peripheral—Doxorubicin—kidney cancer	0.000193	0.000707	CcSEcCtD
Cyclobenzaprine—Jaundice—Doxorubicin—kidney cancer	0.000192	0.000703	CcSEcCtD
Cyclobenzaprine—Stomatitis—Doxorubicin—kidney cancer	0.000192	0.000703	CcSEcCtD
Cyclobenzaprine—Shock—Capecitabine—kidney cancer	0.000192	0.000702	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Capecitabine—kidney cancer	0.000191	0.000698	CcSEcCtD
Cyclobenzaprine—Tachycardia—Capecitabine—kidney cancer	0.00019	0.000696	CcSEcCtD
Cyclobenzaprine—Vomiting—Vincristine—kidney cancer	0.00019	0.000696	CcSEcCtD
Cyclobenzaprine—Sweating—Doxorubicin—kidney cancer	0.000189	0.000691	CcSEcCtD
Cyclobenzaprine—Urticaria—Paclitaxel—kidney cancer	0.000189	0.000691	CcSEcCtD
Cyclobenzaprine—Rash—Vincristine—kidney cancer	0.000189	0.00069	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Capecitabine—kidney cancer	0.000189	0.00069	CcSEcCtD
Cyclobenzaprine—Dermatitis—Vincristine—kidney cancer	0.000189	0.000689	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Paclitaxel—kidney cancer	0.000188	0.000687	CcSEcCtD
Cyclobenzaprine—Headache—Vincristine—kidney cancer	0.000188	0.000686	CcSEcCtD
Cyclobenzaprine—Anorexia—Capecitabine—kidney cancer	0.000186	0.00068	CcSEcCtD
Cyclobenzaprine—Agranulocytosis—Doxorubicin—kidney cancer	0.000184	0.000673	CcSEcCtD
Cyclobenzaprine—Hypotension—Capecitabine—kidney cancer	0.000182	0.000667	CcSEcCtD
Cyclobenzaprine—Vomiting—Gemcitabine—kidney cancer	0.000181	0.00066	CcSEcCtD
Cyclobenzaprine—Rash—Gemcitabine—kidney cancer	0.000179	0.000655	CcSEcCtD
Cyclobenzaprine—Dermatitis—Gemcitabine—kidney cancer	0.000179	0.000654	CcSEcCtD
Cyclobenzaprine—Headache—Gemcitabine—kidney cancer	0.000178	0.00065	CcSEcCtD
Cyclobenzaprine—Nausea—Vincristine—kidney cancer	0.000178	0.00065	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Capecitabine—kidney cancer	0.000178	0.00065	CcSEcCtD
Cyclobenzaprine—Tamoxifen—CYP1A1—kidney cancer	0.000177	0.0219	CrCbGaD
Cyclobenzaprine—Hepatitis—Doxorubicin—kidney cancer	0.000177	0.000647	CcSEcCtD
Cyclobenzaprine—Insomnia—Capecitabine—kidney cancer	0.000176	0.000645	CcSEcCtD
Cyclobenzaprine—Hypoaesthesia—Doxorubicin—kidney cancer	0.000176	0.000644	CcSEcCtD
Cyclobenzaprine—Pharyngitis—Doxorubicin—kidney cancer	0.000176	0.000642	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Capecitabine—kidney cancer	0.000175	0.000641	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Paclitaxel—kidney cancer	0.000175	0.00064	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Capecitabine—kidney cancer	0.000174	0.000636	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Capecitabine—kidney cancer	0.000172	0.000628	CcSEcCtD
Cyclobenzaprine—Asthenia—Paclitaxel—kidney cancer	0.000171	0.000624	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Capecitabine—kidney cancer	0.00017	0.00062	CcSEcCtD
Cyclobenzaprine—Nausea—Gemcitabine—kidney cancer	0.000169	0.000617	CcSEcCtD
Cyclobenzaprine—Fatigue—Capecitabine—kidney cancer	0.000168	0.000615	CcSEcCtD
Cyclobenzaprine—Pruritus—Paclitaxel—kidney cancer	0.000168	0.000615	CcSEcCtD
Cyclobenzaprine—Constipation—Capecitabine—kidney cancer	0.000167	0.00061	CcSEcCtD
Cyclobenzaprine—Tinnitus—Doxorubicin—kidney cancer	0.000165	0.000603	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Paclitaxel—kidney cancer	0.000163	0.000595	CcSEcCtD
Cyclobenzaprine—Feeling abnormal—Capecitabine—kidney cancer	0.000161	0.000588	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Capecitabine—kidney cancer	0.00016	0.000583	CcSEcCtD
Cyclobenzaprine—Arrhythmia—Doxorubicin—kidney cancer	0.000158	0.000578	CcSEcCtD
Cyclobenzaprine—Dizziness—Paclitaxel—kidney cancer	0.000157	0.000575	CcSEcCtD
Cyclobenzaprine—Alopecia—Doxorubicin—kidney cancer	0.000156	0.000572	CcSEcCtD
Cyclobenzaprine—Urticaria—Capecitabine—kidney cancer	0.000155	0.000567	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Capecitabine—kidney cancer	0.000154	0.000564	CcSEcCtD
Cyclobenzaprine—Flatulence—Doxorubicin—kidney cancer	0.000152	0.000555	CcSEcCtD
Cyclobenzaprine—Tension—Doxorubicin—kidney cancer	0.000151	0.000553	CcSEcCtD
Cyclobenzaprine—Vomiting—Paclitaxel—kidney cancer	0.000151	0.000553	CcSEcCtD
Cyclobenzaprine—Dysgeusia—Doxorubicin—kidney cancer	0.000151	0.000552	CcSEcCtD
Cyclobenzaprine—Rash—Paclitaxel—kidney cancer	0.00015	0.000548	CcSEcCtD
Cyclobenzaprine—Dermatitis—Paclitaxel—kidney cancer	0.00015	0.000548	CcSEcCtD
Cyclobenzaprine—Nervousness—Doxorubicin—kidney cancer	0.00015	0.000547	CcSEcCtD
Cyclobenzaprine—Headache—Paclitaxel—kidney cancer	0.000149	0.000545	CcSEcCtD
Cyclobenzaprine—Vision blurred—Doxorubicin—kidney cancer	0.000145	0.000531	CcSEcCtD
Cyclobenzaprine—Hypersensitivity—Capecitabine—kidney cancer	0.000144	0.000526	CcSEcCtD
Cyclobenzaprine—Ill-defined disorder—Doxorubicin—kidney cancer	0.000143	0.000523	CcSEcCtD
Cyclobenzaprine—Agitation—Doxorubicin—kidney cancer	0.000142	0.000518	CcSEcCtD
Cyclobenzaprine—Nausea—Paclitaxel—kidney cancer	0.000141	0.000516	CcSEcCtD
Cyclobenzaprine—Asthenia—Capecitabine—kidney cancer	0.00014	0.000512	CcSEcCtD
Cyclobenzaprine—Malaise—Doxorubicin—kidney cancer	0.000139	0.000508	CcSEcCtD
Cyclobenzaprine—Vertigo—Doxorubicin—kidney cancer	0.000138	0.000506	CcSEcCtD
Cyclobenzaprine—Syncope—Doxorubicin—kidney cancer	0.000138	0.000505	CcSEcCtD
Cyclobenzaprine—Pruritus—Capecitabine—kidney cancer	0.000138	0.000505	CcSEcCtD
Cyclobenzaprine—Leukopenia—Doxorubicin—kidney cancer	0.000138	0.000504	CcSEcCtD
Cyclobenzaprine—Palpitations—Doxorubicin—kidney cancer	0.000136	0.000498	CcSEcCtD
Cyclobenzaprine—Loss of consciousness—Doxorubicin—kidney cancer	0.000135	0.000495	CcSEcCtD
Cyclobenzaprine—Convulsion—Doxorubicin—kidney cancer	0.000134	0.000488	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Capecitabine—kidney cancer	0.000133	0.000488	CcSEcCtD
Cyclobenzaprine—Hypertension—Doxorubicin—kidney cancer	0.000133	0.000486	CcSEcCtD
Cyclobenzaprine—Chest pain—Doxorubicin—kidney cancer	0.000131	0.00048	CcSEcCtD
Cyclobenzaprine—Myalgia—Doxorubicin—kidney cancer	0.000131	0.00048	CcSEcCtD
Cyclobenzaprine—Anxiety—Doxorubicin—kidney cancer	0.000131	0.000478	CcSEcCtD
Cyclobenzaprine—Discomfort—Doxorubicin—kidney cancer	0.00013	0.000474	CcSEcCtD
Cyclobenzaprine—Dizziness—Capecitabine—kidney cancer	0.000129	0.000472	CcSEcCtD
Cyclobenzaprine—Dry mouth—Doxorubicin—kidney cancer	0.000128	0.000469	CcSEcCtD
Cyclobenzaprine—Carbamazepine—ABCB1—kidney cancer	0.000127	0.0157	CrCbGaD
Cyclobenzaprine—Confusional state—Doxorubicin—kidney cancer	0.000127	0.000464	CcSEcCtD
Cyclobenzaprine—Oedema—Doxorubicin—kidney cancer	0.000126	0.00046	CcSEcCtD
Cyclobenzaprine—Anaphylactic shock—Doxorubicin—kidney cancer	0.000126	0.00046	CcSEcCtD
Cyclobenzaprine—Vomiting—Capecitabine—kidney cancer	0.000124	0.000454	CcSEcCtD
Cyclobenzaprine—Shock—Doxorubicin—kidney cancer	0.000124	0.000452	CcSEcCtD
Cyclobenzaprine—Thrombocytopenia—Doxorubicin—kidney cancer	0.000123	0.00045	CcSEcCtD
Cyclobenzaprine—Rash—Capecitabine—kidney cancer	0.000123	0.00045	CcSEcCtD
Cyclobenzaprine—Dermatitis—Capecitabine—kidney cancer	0.000123	0.000449	CcSEcCtD
Cyclobenzaprine—Tachycardia—Doxorubicin—kidney cancer	0.000123	0.000449	CcSEcCtD
Cyclobenzaprine—Headache—Capecitabine—kidney cancer	0.000122	0.000447	CcSEcCtD
Cyclobenzaprine—Hyperhidrosis—Doxorubicin—kidney cancer	0.000122	0.000445	CcSEcCtD
Cyclobenzaprine—Anorexia—Doxorubicin—kidney cancer	0.00012	0.000438	CcSEcCtD
Cyclobenzaprine—Hypotension—Doxorubicin—kidney cancer	0.000118	0.00043	CcSEcCtD
Cyclobenzaprine—Nausea—Capecitabine—kidney cancer	0.000116	0.000424	CcSEcCtD
Cyclobenzaprine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	0.000115	0.000419	CcSEcCtD
Cyclobenzaprine—Insomnia—Doxorubicin—kidney cancer	0.000114	0.000416	CcSEcCtD
Cyclobenzaprine—Paraesthesia—Doxorubicin—kidney cancer	0.000113	0.000413	CcSEcCtD
Cyclobenzaprine—Dyspnoea—Doxorubicin—kidney cancer	0.000112	0.00041	CcSEcCtD
Cyclobenzaprine—Somnolence—Doxorubicin—kidney cancer	0.000112	0.000409	CcSEcCtD
Cyclobenzaprine—Dyspepsia—Doxorubicin—kidney cancer	0.000111	0.000405	CcSEcCtD
Cyclobenzaprine—Decreased appetite—Doxorubicin—kidney cancer	0.000109	0.0004	CcSEcCtD
Cyclobenzaprine—Fatigue—Doxorubicin—kidney cancer	0.000108	0.000396	CcSEcCtD
Cyclobenzaprine—Constipation—Doxorubicin—kidney cancer	0.000108	0.000393	CcSEcCtD
Cyclobenzaprine—Chlorprothixene—ABCB1—kidney cancer	0.000107	0.0132	CrCbGaD
Cyclobenzaprine—Feeling abnormal—Doxorubicin—kidney cancer	0.000104	0.000379	CcSEcCtD
Cyclobenzaprine—Gastrointestinal pain—Doxorubicin—kidney cancer	0.000103	0.000376	CcSEcCtD
Cyclobenzaprine—Urticaria—Doxorubicin—kidney cancer	9.99e-05	0.000365	CcSEcCtD
Cyclobenzaprine—Abdominal pain—Doxorubicin—kidney cancer	9.94e-05	0.000363	CcSEcCtD
Cyclobenzaprine—Trimipramine—ABCB1—kidney cancer	9.84e-05	0.0122	CrCbGaD
Cyclobenzaprine—Promethazine—ABCB1—kidney cancer	9.48e-05	0.0117	CrCbGaD
Cyclobenzaprine—Tamoxifen—ABCB1—kidney cancer	9.41e-05	0.0116	CrCbGaD
Cyclobenzaprine—Doxepin—ABCB1—kidney cancer	9.38e-05	0.0116	CrCbGaD
Cyclobenzaprine—Hypersensitivity—Doxorubicin—kidney cancer	9.27e-05	0.000339	CcSEcCtD
Cyclobenzaprine—Asthenia—Doxorubicin—kidney cancer	9.02e-05	0.00033	CcSEcCtD
Cyclobenzaprine—Pruritus—Doxorubicin—kidney cancer	8.9e-05	0.000325	CcSEcCtD
Cyclobenzaprine—Diarrhoea—Doxorubicin—kidney cancer	8.6e-05	0.000315	CcSEcCtD
Cyclobenzaprine—Dizziness—Doxorubicin—kidney cancer	8.32e-05	0.000304	CcSEcCtD
Cyclobenzaprine—Vomiting—Doxorubicin—kidney cancer	8e-05	0.000292	CcSEcCtD
Cyclobenzaprine—Rash—Doxorubicin—kidney cancer	7.93e-05	0.00029	CcSEcCtD
Cyclobenzaprine—Dermatitis—Doxorubicin—kidney cancer	7.92e-05	0.00029	CcSEcCtD
Cyclobenzaprine—Headache—Doxorubicin—kidney cancer	7.88e-05	0.000288	CcSEcCtD
Cyclobenzaprine—Nausea—Doxorubicin—kidney cancer	7.47e-05	0.000273	CcSEcCtD
Cyclobenzaprine—Imipramine—ABCB1—kidney cancer	7.3e-05	0.00903	CrCbGaD
Cyclobenzaprine—Amitriptyline—ABCB1—kidney cancer	7.26e-05	0.00897	CrCbGaD
Cyclobenzaprine—CYP2D6—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	8.56e-06	0.00428	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Arachidonic acid metabolism—CYP1A1—kidney cancer	8.51e-06	0.00425	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—ANXA1—kidney cancer	8.02e-06	0.00401	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—OR4C13—kidney cancer	7.85e-06	0.00392	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	7.35e-06	0.00367	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	7.26e-06	0.00362	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—kidney cancer	7.14e-06	0.00357	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	7.04e-06	0.00351	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Tryptophan metabolism—CYP1A1—kidney cancer	7.02e-06	0.00351	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—ALDH1A1—kidney cancer	6.89e-06	0.00344	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	6.47e-06	0.00323	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GSTP1—kidney cancer	6.21e-06	0.0031	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTT1—kidney cancer	6.19e-06	0.00309	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—HIF1A—kidney cancer	6.06e-06	0.00303	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	5.96e-06	0.00298	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—ANXA1—kidney cancer	5.94e-06	0.00297	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—PTGS1—kidney cancer	5.8e-06	0.0029	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase II conjugation—GSTM1—kidney cancer	5.71e-06	0.00285	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—kidney cancer	5.67e-06	0.00283	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—kidney cancer	5.6e-06	0.0028	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—kidney cancer	5.59e-06	0.00279	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—RELA—kidney cancer	5.57e-06	0.00278	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	5.48e-06	0.00274	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—kidney cancer	5.41e-06	0.0027	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Phase 1 - Functionalization of compounds—POMC—kidney cancer	5.25e-06	0.00262	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTT1—kidney cancer	5.24e-06	0.00262	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—kidney cancer	5.12e-06	0.00256	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—kidney cancer	5.12e-06	0.00256	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Arachidonic acid metabolism—PTGS2—kidney cancer	5.06e-06	0.00253	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—kidney cancer	5.01e-06	0.0025	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—PTGS1—kidney cancer	4.91e-06	0.00245	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—kidney cancer	4.88e-06	0.00244	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—OR4C13—kidney cancer	4.64e-06	0.00232	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—kidney cancer	4.6e-06	0.0023	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—ANXA1—kidney cancer	4.53e-06	0.00226	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Phase 1 - Functionalization of compounds—POMC—kidney cancer	4.44e-06	0.00222	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—GLIPR1—kidney cancer	4.33e-06	0.00216	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTP1—kidney cancer	4.29e-06	0.00214	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—kidney cancer	4.26e-06	0.00213	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—GSTP1—kidney cancer	4.23e-06	0.00211	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—kidney cancer	4.23e-06	0.00211	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTT1—kidney cancer	4.05e-06	0.00202	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—LATS1—kidney cancer	3.94e-06	0.00197	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—GSTM1—kidney cancer	3.94e-06	0.00197	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—kidney cancer	3.92e-06	0.00196	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—GSTM1—kidney cancer	3.89e-06	0.00194	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—kidney cancer	3.83e-06	0.00192	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—PTGS1—kidney cancer	3.79e-06	0.00189	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—CYP1A1—kidney cancer	3.74e-06	0.00187	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metapathway biotransformation—CYP1A1—kidney cancer	3.69e-06	0.00184	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—JUN—kidney cancer	3.65e-06	0.00183	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTP1—kidney cancer	3.63e-06	0.00182	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—kidney cancer	3.63e-06	0.00181	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—kidney cancer	3.62e-06	0.00181	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—AKAP13—kidney cancer	3.59e-06	0.00179	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—GSTP1—kidney cancer	3.58e-06	0.00179	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Phase 1 - Functionalization of compounds—POMC—kidney cancer	3.43e-06	0.00171	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AMER1—kidney cancer	3.35e-06	0.00167	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—GSTM1—kidney cancer	3.34e-06	0.00167	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—GSTM1—kidney cancer	3.29e-06	0.00165	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ACY1—kidney cancer	3.29e-06	0.00164	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—AKAP13—kidney cancer	3.26e-06	0.00163	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—kidney cancer	3.24e-06	0.00162	CbGpPWpGaD
Cyclobenzaprine—HTR2A—SIDS Susceptibility Pathways—VEGFA—kidney cancer	3.19e-06	0.00159	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—CYP1A1—kidney cancer	3.17e-06	0.00158	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metapathway biotransformation—CYP1A1—kidney cancer	3.12e-06	0.00156	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ITPR2—kidney cancer	3.05e-06	0.00152	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Class A/1 (Rhodopsin-like receptors)—POMC—kidney cancer	2.91e-06	0.00145	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GPC3—kidney cancer	2.81e-06	0.0014	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CER1—kidney cancer	2.81e-06	0.0014	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTP1—kidney cancer	2.8e-06	0.0014	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PDHB—kidney cancer	2.8e-06	0.0014	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Biological oxidations—POMC—kidney cancer	2.79e-06	0.00139	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ACY1—kidney cancer	2.78e-06	0.00139	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ITPR2—kidney cancer	2.77e-06	0.00138	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTP1—kidney cancer	2.77e-06	0.00138	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CCBL1—kidney cancer	2.63e-06	0.00131	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—GSTM1—kidney cancer	2.58e-06	0.00129	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—ANXA1—kidney cancer	2.56e-06	0.00128	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—GSTM1—kidney cancer	2.54e-06	0.00127	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—CYP1A1—kidney cancer	2.44e-06	0.00122	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	2.41e-06	0.0012	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—SFRP2—kidney cancer	2.39e-06	0.00119	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CRABP1—kidney cancer	2.37e-06	0.00119	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PDHB—kidney cancer	2.37e-06	0.00118	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Biological oxidations—POMC—kidney cancer	2.36e-06	0.00118	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—kidney cancer	2.34e-06	0.00117	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—ANXA1—kidney cancer	2.32e-06	0.00116	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GLIPR1—kidney cancer	2.28e-06	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PPAT—kidney cancer	2.28e-06	0.00114	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CCBL1—kidney cancer	2.23e-06	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—kidney cancer	2.22e-06	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR ligand binding—POMC—kidney cancer	2.22e-06	0.00111	CbGpPWpGaD
Cyclobenzaprine—HTR2A—G alpha (q) signalling events—PIK3CA—kidney cancer	2.16e-06	0.00108	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ACY1—kidney cancer	2.15e-06	0.00107	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—APRT—kidney cancer	2.12e-06	0.00106	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—FH—kidney cancer	2.12e-06	0.00106	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—kidney cancer	2.1e-06	0.00105	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	2.01e-06	0.00101	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GPC3—kidney cancer	1.99e-06	0.000995	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CA2—kidney cancer	1.94e-06	0.000968	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PPAT—kidney cancer	1.93e-06	0.000964	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.93e-06	0.000964	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—kidney cancer	1.93e-06	0.000964	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CASP2—kidney cancer	1.93e-06	0.000962	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—AKAP13—kidney cancer	1.93e-06	0.000962	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.91e-06	0.000952	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALAD—kidney cancer	1.89e-06	0.000943	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.89e-06	0.000942	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.84e-06	0.00092	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PDHB—kidney cancer	1.83e-06	0.000913	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Biological oxidations—POMC—kidney cancer	1.82e-06	0.00091	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.8e-06	0.0009	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—APRT—kidney cancer	1.79e-06	0.000896	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—FH—kidney cancer	1.79e-06	0.000896	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—GRB7—kidney cancer	1.76e-06	0.00088	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.75e-06	0.000876	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PGK1—kidney cancer	1.73e-06	0.000862	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.73e-06	0.000862	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CCBL1—kidney cancer	1.72e-06	0.000858	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—LDHB—kidney cancer	1.69e-06	0.000846	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GPC3—kidney cancer	1.69e-06	0.000843	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CA2—kidney cancer	1.64e-06	0.00082	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ITPR2—kidney cancer	1.64e-06	0.000818	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALAD—kidney cancer	1.6e-06	0.000799	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ST3GAL2—kidney cancer	1.56e-06	0.00078	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ALDH1A1—kidney cancer	1.53e-06	0.000762	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GLIPR1—kidney cancer	1.49e-06	0.000744	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PPAT—kidney cancer	1.49e-06	0.000744	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CTNNA1—kidney cancer	1.48e-06	0.000741	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—EIF4EBP1—kidney cancer	1.48e-06	0.000737	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HSPB1—kidney cancer	1.48e-06	0.000737	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CA9—kidney cancer	1.47e-06	0.000733	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC5A3—kidney cancer	1.46e-06	0.000731	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PGK1—kidney cancer	1.46e-06	0.000731	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—LDHB—kidney cancer	1.43e-06	0.000717	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—FH—kidney cancer	1.38e-06	0.000692	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—APRT—kidney cancer	1.38e-06	0.000692	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PSMD7—kidney cancer	1.37e-06	0.000685	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ANXA1—kidney cancer	1.37e-06	0.000685	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TSC1—kidney cancer	1.37e-06	0.000685	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—FLT1—kidney cancer	1.33e-06	0.000664	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GPC3—kidney cancer	1.3e-06	0.00065	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CA2—kidney cancer	1.27e-06	0.000633	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—POMC—kidney cancer	1.25e-06	0.000626	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CRABP1—kidney cancer	1.25e-06	0.000624	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CA9—kidney cancer	1.24e-06	0.000621	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALAD—kidney cancer	1.23e-06	0.000617	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—JUNB—kidney cancer	1.23e-06	0.000615	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PAK1—kidney cancer	1.23e-06	0.000615	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.22e-06	0.000607	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	1.2e-06	0.000602	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	1.18e-06	0.000588	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ITPR2—kidney cancer	1.16e-06	0.00058	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—POMC—kidney cancer	1.14e-06	0.000568	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC5A3—kidney cancer	1.13e-06	0.000564	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PGK1—kidney cancer	1.13e-06	0.000564	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—LDHB—kidney cancer	1.11e-06	0.000553	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTT1—kidney cancer	1.06e-06	0.000529	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ACHE—kidney cancer	1.06e-06	0.000529	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CRABP1—kidney cancer	1.06e-06	0.000528	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF2—kidney cancer	1.01e-06	0.000503	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN2B—kidney cancer	1e-06	0.000501	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SCARB1—kidney cancer	1e-06	0.0005	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS1—kidney cancer	9.92e-07	0.000495	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ITPR2—kidney cancer	9.83e-07	0.000491	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IGF1R—kidney cancer	9.74e-07	0.000486	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PSMD7—kidney cancer	9.73e-07	0.000486	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CA9—kidney cancer	9.6e-07	0.000479	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—RAF1—kidney cancer	9.38e-07	0.000469	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—IL2—kidney cancer	9.26e-07	0.000463	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—BCHE—kidney cancer	9.22e-07	0.000461	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC5A5—kidney cancer	9.11e-07	0.000455	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	9.06e-07	0.000453	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTT1—kidney cancer	8.97e-07	0.000448	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ACHE—kidney cancer	8.97e-07	0.000448	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—SLC2A1—kidney cancer	8.8e-07	0.000439	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SCARB1—kidney cancer	8.49e-07	0.000424	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—IL2—kidney cancer	8.41e-07	0.00042	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS1—kidney cancer	8.4e-07	0.00042	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PSMD7—kidney cancer	8.24e-07	0.000412	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CRABP1—kidney cancer	8.16e-07	0.000408	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—HIF1A—kidney cancer	8.01e-07	0.0004	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TSC2—kidney cancer	7.99e-07	0.000399	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—BCHE—kidney cancer	7.81e-07	0.00039	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC5A5—kidney cancer	7.72e-07	0.000385	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KDR—kidney cancer	7.66e-07	0.000383	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ITPR2—kidney cancer	7.59e-07	0.000379	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—SLC2A1—kidney cancer	7.45e-07	0.000372	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTP1—kidney cancer	7.34e-07	0.000366	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	7.23e-07	0.000361	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—APC—kidney cancer	7.06e-07	0.000353	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KIT—kidney cancer	7.06e-07	0.000353	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—ABCB1—kidney cancer	6.94e-07	0.000347	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ACHE—kidney cancer	6.92e-07	0.000346	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTT1—kidney cancer	6.92e-07	0.000346	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAPK3—kidney cancer	6.76e-07	0.000338	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—GSTM1—kidney cancer	6.74e-07	0.000337	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—POMC—kidney cancer	6.72e-07	0.000336	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—BRAF—kidney cancer	6.64e-07	0.000331	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SCARB1—kidney cancer	6.55e-07	0.000327	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS1—kidney cancer	6.48e-07	0.000324	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—MAPK1—kidney cancer	6.43e-07	0.000321	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—CYP1A1—kidney cancer	6.39e-07	0.000319	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PSMD7—kidney cancer	6.36e-07	0.000318	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	6.3e-07	0.000315	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTP1—kidney cancer	6.21e-07	0.00031	CbGpPWpGaD
Cyclobenzaprine—HTR2A—GPCR downstream signaling—PIK3CA—kidney cancer	6.15e-07	0.000307	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—KRAS—kidney cancer	6.08e-07	0.000304	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—BCHE—kidney cancer	6.03e-07	0.000301	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC5A5—kidney cancer	5.95e-07	0.000297	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—ABCB1—kidney cancer	5.88e-07	0.000294	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—SLC2A1—kidney cancer	5.75e-07	0.000287	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—GSTM1—kidney cancer	5.71e-07	0.000285	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling by GPCR—PIK3CA—kidney cancer	5.58e-07	0.000279	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RAF1—kidney cancer	5.54e-07	0.000277	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—RELA—kidney cancer	5.52e-07	0.000276	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—ERBB2—kidney cancer	5.48e-07	0.000274	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—CYP1A1—kidney cancer	5.41e-07	0.00027	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MTOR—kidney cancer	5.41e-07	0.00027	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CDKN1B—kidney cancer	5.08e-07	0.000254	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—IL2—kidney cancer	4.97e-07	0.000248	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CCND1—kidney cancer	4.84e-07	0.000242	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—JUN—kidney cancer	4.83e-07	0.000241	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—CTNNB1—kidney cancer	4.8e-07	0.00024	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTP1—kidney cancer	4.8e-07	0.00024	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—POMC—kidney cancer	4.76e-07	0.000238	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PTEN—kidney cancer	4.67e-07	0.000234	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—ABCB1—kidney cancer	4.54e-07	0.000227	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.45e-07	0.000222	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—GSTM1—kidney cancer	4.41e-07	0.00022	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—VEGFA—kidney cancer	4.22e-07	0.000211	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—CYP1A1—kidney cancer	4.18e-07	0.000209	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—POMC—kidney cancer	4.04e-07	0.000202	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK3—kidney cancer	3.99e-07	0.0002	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MYC—kidney cancer	3.89e-07	0.000194	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—MAPK1—kidney cancer	3.8e-07	0.00019	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTGS2—kidney cancer	3.8e-07	0.00019	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—KRAS—kidney cancer	3.59e-07	0.000179	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PTEN—kidney cancer	3.31e-07	0.000166	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—PIK3CA—kidney cancer	3.3e-07	0.000165	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTGS2—kidney cancer	3.22e-07	0.000161	CbGpPWpGaD
Cyclobenzaprine—HTR2A—Signaling Pathways—TP53—kidney cancer	3.19e-07	0.000159	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—POMC—kidney cancer	3.12e-07	0.000156	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PTEN—kidney cancer	2.81e-07	0.00014	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTGS2—kidney cancer	2.48e-07	0.000124	CbGpPWpGaD
Cyclobenzaprine—CYP2D6—Metabolism—PIK3CA—kidney cancer	2.34e-07	0.000117	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PTEN—kidney cancer	2.17e-07	0.000108	CbGpPWpGaD
Cyclobenzaprine—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.98e-07	9.89e-05	CbGpPWpGaD
Cyclobenzaprine—CYP3A4—Metabolism—PIK3CA—kidney cancer	1.53e-07	7.64e-05	CbGpPWpGaD
